Short-term efficacy and safety of rituximab therapy in refractory systemic lupus erythematosus: results from the British Isles Lupus Assessment Group Biologics …

EM McCarthy, E Sutton, S Nesbit, J White… - …, 2018 - academic.oup.com
Objectives To describe the baseline characteristics of SLE patients requiring biologic therapy
in the UK and to explore short term efficacy and infection rates associated with rituximab (…

[HTML][HTML] Endothelial microparticles prevent lipid-induced endothelial damage via Akt/eNOS signaling and reduced oxidative stress

AM Mahmoud, FL Wilkinson, EM McCarthy… - The FASEB …, 2017 - ncbi.nlm.nih.gov
Endothelial microparticles (EMPs) are endothelium-derived submicron vesicles that are
released in response to diverse stimuli and are elevated in cardiovascular disease, which is …

The association of cytokines with disease activity and damage scores in systemic lupus erythematosus patients

EM McCarthy, S Smith, RZ Lee, G Cunnane… - …, 2014 - academic.oup.com
Objective. The aim of this study was to explore the role of cytokines in the pathogenesis of
SLE in a genetically homogeneous Caucasian SLE patient population. Methods. Serum levels …

[HTML][HTML] Cytokine profiling in active and quiescent SLE reveals distinct patient subpopulations

JA Reynolds, EM McCarthy, S Haque… - Arthritis research & …, 2018 - Springer
Background Patients with SLE display marked clinical and immunlogical heterogeneity. The
purpose of the study was to investigate patterns of serum cytokines in patients with active …

Elevated B lymphocyte stimulator levels are associated with increased damage in an Irish systemic lupus erythematosus cohort

EM McCarthy, RZ Lee, J Ní Gabhann, S Smith… - …, 2013 - academic.oup.com
Objective. The overall aim of this study is to identify clinical and serological features that are
associated with B lymphocyte stimulator (BLyS) elevation in a homogeneous Caucasian …

[HTML][HTML] IL-16/miR-125a axis controls neutrophil recruitment in pristane-induced lung inflammation

…, JN Gabhann, K Cunningham, A Widaa, EM McCarthy… - JCI insight, 2018 - ncbi.nlm.nih.gov
Severe lung inflammation and alveolar hemorrhage can be life-threatening in systemic lupus
erythematosus (SLE) patients if not treated early and aggressively. Neutrophil influx is the …

Knowledge, attitudes, and clinical practice of rheumatologists in vaccination of the at-risk rheumatology patient population

EM McCarthy, MA Azeez, FM Fitzpatrick… - JCR: Journal of …, 2012 - journals.lww.com
Background Patients with inflammatory arthritis are at increased risk of infection. Much of
the burden of infection in this population is vaccine preventable. A number of international …

Clinicians approaches to management of background treatment in patients with SLE in clinical remission: results of an international observational survey

P Ngamjanyaporn, EM McCarthy… - Lupus Science & …, 2017 - lupus.bmj.com
Background The definition of remission in systemic lupus erythematosus (SLE) remains
unclear, especially how background treatment should be interpreted. Objective To determine …

[HTML][HTML] Type I interferon in patients with systemic autoimmune rheumatic disease is associated with haematological abnormalities and specific autoantibody profiles

…, S Haque, H Chinoy, AL Herrick, EM McCarthy… - Arthritis research & …, 2019 - Springer
Objectives To investigate the relationships between interferon alpha (IFNα) and the clinical
and serological phenotype of patients with systemic autoimmune rheumatic disease (SARDs) …

QRISK3 improves detection of cardiovascular disease risk in patients with systemic lupus erythematosus

…, JA Reynolds, MY Alexander, EM McCarthy… - Lupus science & …, 2018 - lupus.bmj.com
Objective 10-year cardiovascular disease (CVD) risk scores are calculated using algorithms,
including Framingham (worldwide) and QRISK2 (UK). Recently, an updated QRISK3 model …